undamentalytics Newsletter

Cryoport, Inc. balance sheet

At the end of fiscal 2025, Cryoport, Inc. had total assets of $765m, total liabilities of $262m and shareholders' equity of $503m. It held $250m in cash against $186m of debt: net cash of $64.2m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Cryoport, Inc.: balance sheet, annual
Fiscal year2011Mar 20112012Mar 20122013Mar 20132014Mar 20142015Mar 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents—————515374737139293534250269
Receivables00011124731394442253336
Inventory00000000011172826212322
Total current assets10511261752103147694604535342476460
Goodwill———————01114514715176212222
Total assets116223820571365521,1131,039958703765756
Deferred revenue (current)——————0000101112
Total current liabilities3124322353543414665219221
Long-term debt—01—————05101111
Total debt201—100150115404407379198186187
Total liabilities52443221810170471483469302262266
Shareholders' equity64−2−2−061839126383642556489402503491
Net debt (negative = net cash)—————−5−15−23−4778265378344164−64−82
Shares outstanding————15m18m26m30m37m40m50m48m49m50m50m51m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CTKB vs CYRXCYRX vs MRVICYRX vs GRALCYRX vs PACB

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Cryoport, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cryoport, Inc.